These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 323298)

  • 1. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance of potassium balance during diuretic therapy.
    Kohvakka A; Eisalo A; Manninen V
    Acta Med Scand; 1979; 205(4):319-24. PubMed ID: 373393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide in combination with potassium-sparing agents in the treatment of hypertension.
    Dean S; Spencer-Mills L
    Curr Med Res Opin; 1984; 9(5):287-9. PubMed ID: 6397330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of hydrochlorothiazide plus triameterene therapy versus chlorthalidone therapy in hypertension.
    Clark EC; Podolsky S; Thompson EJ
    South Med J; 1979 Jul; 72(7):798-802. PubMed ID: 377507
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cross-over study on therapy indicators and blood pressure lowering action of beta-receptor blocker atenolol and the diuretic combination triamterene/hydrochlorothiazide].
    Walter U; Cordes U; Philipp T; Distler A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():311-4. PubMed ID: 347804
    [No Abstract]   [Full Text] [Related]  

  • 9. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS; Johnson CA; Kotchen JM; Kotchen TA
    Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].
    Sanguigni D; Benvenuti C
    Clin Ter; 1978 Oct; 87(1):69-74. PubMed ID: 737980
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combination.
    Nash DT
    J Med; 1977; 8(5):367-77. PubMed ID: 338851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
    Casner PR; Dillon KR
    J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B
    J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension.
    Schnaper HW; Maxwell MH
    Am J Cardiol; 1989 Jan; 63(4):32B-36B. PubMed ID: 2643290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrochlorothiazide and spironolactone in hypertension.
    Schrijver G; Weinberger MH
    Clin Pharmacol Ther; 1979 Jan; 25(1):33-42. PubMed ID: 363334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
    Woo J; Woo KS; Kin T; Vallance-Owen J
    Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.